Survival analysis showed that NMU/Col1a1/YAP1 expression was associated with poor overall survival, and NMU expression was the highest in pancreatic adenocarcinoma patients with pancreatitis in TCGA (Figure S5). This evidence concerns the gene COL1A1 and pancreatitis.